November, Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte, Inc. (NASDAQ:HUMA) stock and set a price target of $11. Humacyte, Inc.
Latest News
HEDGE FLOW Hedge funds ditched tech stocks in Japan and Hong Kong last week, says Goldman
Hedge funds sold Hong Kong and Japanese stocks last week, Goldman Sachs said in a note, just before the tech-heavy Hang Seng and Nikkei
Can quantum computing stocks IonQ, Rigetti Computing, and D-Wave Quantum become the next Nvidia? History offers some big clues.
Historical precedent hasn’t been kind to next-big-thing technologies — and quantum computing doesn’t look to be an exception.
JPMorgan pushes deeper into crypto strategy with MONY fund on Ethereum: Report
The product runs on Ethereum while being supported by the bank’s permissioned Kinexys blockchain platform. ・This is another step in JPMorgan’s positioning of tokenization
Exclusive-Tesla board made $3 billion via stock awards that dwarfed tech peers
Tesla’s board of directors has earned more than $3 billion through stock awards that far exceeded the value of those given to peers at
AARP Wisconsin wants to see more protections against scams utilizing cryptocurrency kiosks
AARP is urging Wisconsin lawmakers to better protect people from cryptocurrency scams, especially when it comes to crypto kiosks.
TSX futures climb with precious metals ahead of Canadian inflation data
Futures for Canada’s main stock index rose on Monday, supported by higher precious metal prices, while investors awaited domestic inflation print due later in
Virginia loses jobs even as unemployment falls
Virginia’s unemployment rate ticked down to 3.5% in the latest preliminary jobs report, Gov. Youngkin announced last week. Why it matters: It’s the first
Top 3 Crypto Events to Watch at Year-End, Bullish Ahead?
Uncover top crypto events shaping year-end markets, as CPI, NFP, and central bank moves drive volatility into 2026.
UK Govt Unveils Plans To Regulate Cryptocurrency In 2027
Britain has announced that it will formally bring cryptocurrency companies under the purview of its financial regulations by 2027, in a sweeping move …